Description:
HEMOCHROMATOSIS; HFE
|
Repository
|
Centers for Disease Control and Prevention Repository
|
| Class |
Disorders of Metal Metabolism |
| Quantity |
10ug |
| Quantitation Method |
Please see our FAQ |
|
Biopsy Source
|
Peripheral vein
|
|
Sample Source
|
DNA from LCL
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Gene |
HFE |
| Chromosomal Location |
6p22.2 |
| Allelic Variant 1 |
613609.0003; HEMOCHROMATOSIS |
| Identified Mutation |
SER65CYS; Mura et al. [Blood 93: 2502-2505 (1999)] reported on the analysis of the cys282-to-tyr (C282Y; 235200.0001), his63-to-asp (H63D; 235200.0002), and ser65-to-cys (S65C) mutations of the HFE gene in a series of 711 probands with hereditary hemochromatosis and 410 controls. The results confirmed that the C282Y substitution is the main mutation involved in HH, accounting for 85% of carrier chromosomes, whereas the H63D substitution represented 39% of the HH chromosomes that did not carry the C282Y mutation. In addition, the screening showed that the S65C substitution, which results from a 193A-T transversion, was significantly enriched in probands with at least one chromosome without an assigned mutation. This substitution accounted for 7.8% of HH chromosomes that were neither C282Y nor H63D. This enrichment of S65C among HH chromosomes suggested that the S65C substitution is associated with a mild form of hemochromatosis. |
| Remarks |
Donor subject has one allele which has an A>T transversion at nucleotide 193 in exon 2 of the HFE (HLA-H) gene [193A>T] resulting in a substitution of cysteine for serine at codon 65 [Ser65Cys (S65C)] and a second allele which tested negative for the C282Y, H63D, and S65C mutations |
|